Reinstatement

Transglutaminase 2 inhibitor abrogates renal cell carcinoma in xenograft models

Reinstatement Details

Nature of Retraction:

Reinstatement

Retraction Notice:
10.1007/s00432-014-1623-5

Citations (32)

32
Total Citations
28
Post-Retraction
(87.5%)
1
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
2 Within 1 year
21 After 2+ years
3439 Days since retraction (latest)
Paper citing Compensatory increase of transglutaminase 2 is res...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Transglutaminase 2 inhibitor abrogates renal cell ...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Compensatory increase of transglutaminase 2 is res...
Unknown Authors
Unknown Journal
Published: Unknown
Paper citing Transglutaminase 2 inhibitor abrogates renal cell ...
Unknown Authors
Unknown Journal
Published: Jun 2024
3439 days after retraction
Paper citing Transglutaminase 2 inhibitor abrogates renal cell ...
Unknown Authors
Unknown Journal
Published: Feb 2024
3318 days after retraction
Paper citing Transglutaminase 2 inhibitor abrogates renal cell ...
Unknown Authors
Unknown Journal
Published: Feb 2024
3318 days after retraction
Paper citing Transglutaminase 2 inhibitor abrogates renal cell ...
Unknown Authors
Unknown Journal
Published: Jul 2023
3116 days after retraction
Paper citing Transglutaminase 2 inhibitor abrogates renal cell ...
Unknown Authors
Unknown Journal
Published: Apr 2023
3035 days after retraction
Paper citing Transglutaminase 2 inhibitor abrogates renal cell ...
Unknown Authors
Unknown Journal
Published: Dec 2022
2918 days after retraction
Paper citing Transglutaminase 2 inhibitor abrogates renal cell ...
Unknown Authors
Unknown Journal
Published: Feb 2021
2248 days after retraction
Paper citing Transglutaminase 2 inhibitor abrogates renal cell ...
Unknown Authors
Unknown Journal
Published: Jul 2020
2024 days after retraction
Paper citing Compensatory increase of transglutaminase 2 is res...
Unknown Authors
Unknown Journal
Published: Jun 2020
1993 days after retraction
Paper citing Compensatory increase of transglutaminase 2 is res...
Unknown Authors
Unknown Journal
Published: Apr 2020
1919 days after retraction
Paper citing Compensatory increase of transglutaminase 2 is res...
Unknown Authors
Unknown Journal
Published: Mar 2019
1547 days after retraction
Transglutaminase 2: The Maestro of the Oncogenic Mediators in Renal Cell Carcinoma
Ayça Ece Nezir, Bürge Ulukan, Dilek Telci
Medical Sciences Open Access
Published: Feb 2019
6 citations
1497 days after retraction
Paper citing Transglutaminase 2 inhibitor abrogates renal cell ...
Unknown Authors
Unknown Journal
Published: Nov 2018
1418 days after retraction
Paper citing Transglutaminase 2 inhibitor abrogates renal cell ...
Unknown Authors
Unknown Journal
Published: Oct 2018
1376 days after retraction
Paper citing Transglutaminase 2 inhibitor abrogates renal cell ...
Unknown Authors
Unknown Journal
Published: Aug 2018
1321 days after retraction
Paper citing Transglutaminase 2 inhibitor abrogates renal cell ...
Unknown Authors
Unknown Journal
Published: Mar 2018
1155 days after retraction
Paper citing Transglutaminase 2 inhibitor abrogates renal cell ...
Unknown Authors
Unknown Journal
Published: Dec 2017
1086 days after retraction
Paper citing Transglutaminase 2 inhibitor abrogates renal cell ...
Unknown Authors
Unknown Journal
Published: Dec 2017
1065 days after retraction
Paper citing Transglutaminase 2 inhibitor abrogates renal cell ...
Unknown Authors
Unknown Journal
Published: Sep 2017
987 days after retraction
Paper citing Transglutaminase 2 inhibitor abrogates renal cell ...
Unknown Authors
Unknown Journal
Published: Sep 2017
974 days after retraction
Paper citing Transglutaminase 2 inhibitor abrogates renal cell ...
Unknown Authors
Unknown Journal
Published: Jun 2017
908 days after retraction
Paper citing Transglutaminase 2 inhibitor abrogates renal cell ...
Unknown Authors
Unknown Journal
Published: Nov 2016
690 days after retraction
Paper citing Transglutaminase 2 inhibitor abrogates renal cell ...
Unknown Authors
Unknown Journal
Published: Nov 2016
670 days after retraction
Paper citing Transglutaminase 2 inhibitor abrogates renal cell ...
Unknown Authors
Unknown Journal
Published: Aug 2016
602 days after retraction
Paper citing Transglutaminase 2 inhibitor abrogates renal cell ...
Unknown Authors
Unknown Journal
Published: Apr 2016
456 days after retraction
Paper citing Transglutaminase 2 inhibitor abrogates renal cell ...
Unknown Authors
Unknown Journal
Published: Mar 2016
425 days after retraction
Paper citing Transglutaminase 2 inhibitor abrogates renal cell ...
Unknown Authors
Unknown Journal
Published: Nov 2015
319 days after retraction
Paper citing Transglutaminase 2 inhibitor abrogates renal cell ...
Unknown Authors
Unknown Journal
Published: Jul 2015
196 days after retraction
Paper citing Transglutaminase 2 inhibitor abrogates renal cell ...
Unknown Authors
Unknown Journal
Published: Dec 2014
15 days before retraction
Quick Stats
Total Citations: 32
Years Since Retraction: 10.9 years
Open Access: Yes
Last Checked: Never
Related Papers
Primary hemostasis dysfunctions and bleeding risk in newly …
Journal of Cancer Research and Clinical Oncology • 2 citations
Wilms tumor-suppressing peptide inhibits proliferation and …
Journal of Cancer Research and Clinical Oncology • 6 citations
The role of lymph node dissection in the surgical treatment…
Journal of Cancer Research and Clinical Oncology • 2 citations
Comprehensive Analysis of Regulatory Network for LINC00472 …
Journal of Healthcare Engineering • 10 citations
Comprehensive Analysis of the Expression and Prognosis for …
Journal of Healthcare Engineering • 10 citations